Tweet
Source: https://newsinfo.inquirer.net/134671...early-november
Indonesia aims to start administering coronavirus vaccines in early November
The Straits Times/Asia News Network / 02:46 PM October 12, 2020
indonesia clinic covid-19
JAKARTA — Indonesia is aiming to start administering coronavirus vaccines in early November by relying on supply from Chinese drugmakers, as the world’s fourth most populous country fights a health crisis that may result in its first recession in more than two decades.
The Coordinating Ministry for Maritime and Investment Affairs on Monday (Oct 12) said 100,000 doses will be supplied by CanSino Biologics, the first Chinese company to test a Covid-19 vaccine on humans, in November.
Sinovac Biotech, a China-based company, will be supplying 3 million doses by December. The firm has been working with Indonesia’s state-owned pharmaceutical company Bio Farma since April on a Covid-19 vaccine.
Another 5 million doses will come, starting November, from a partnership between Chinese state-owned pharmaceutical company Sinopharm and the United Arab Emirates technology company G42.
The three vaccines, which are undergoing third and final phase clinical trials, received emergency use authorization from China, the ministry said in a statement...
Indonesia aims to start administering coronavirus vaccines in early November
The Straits Times/Asia News Network / 02:46 PM October 12, 2020
indonesia clinic covid-19
JAKARTA — Indonesia is aiming to start administering coronavirus vaccines in early November by relying on supply from Chinese drugmakers, as the world’s fourth most populous country fights a health crisis that may result in its first recession in more than two decades.
The Coordinating Ministry for Maritime and Investment Affairs on Monday (Oct 12) said 100,000 doses will be supplied by CanSino Biologics, the first Chinese company to test a Covid-19 vaccine on humans, in November.
Sinovac Biotech, a China-based company, will be supplying 3 million doses by December. The firm has been working with Indonesia’s state-owned pharmaceutical company Bio Farma since April on a Covid-19 vaccine.
Another 5 million doses will come, starting November, from a partnership between Chinese state-owned pharmaceutical company Sinopharm and the United Arab Emirates technology company G42.
The three vaccines, which are undergoing third and final phase clinical trials, received emergency use authorization from China, the ministry said in a statement...